Evidence map›Paper›PMID 39820014›Full record

ArticleJCI insight2025

Prothrombin prevents fatal T cell-dependent anemia during chronic virus infection of mice.

Rachel Cantrell, H Alex Feldman, Leah Rosenfeldt, Ayad Ali, Benjamin Gourley, Cassandra Sprague, Daniel Leino, Jeff Crosby, Alexey Revenko, Brett Monia and 2 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rachel CantrellImmunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
H Alex FeldmanImmunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Leah RosenfeldtDivision of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Ayad AliImmunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Benjamin GourleyDivision of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Cassandra SpragueDivision of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Daniel LeinoDivision of Pathology, Cincinnati Children's Hospital Medical Center and The University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Jeff CrosbyIonis Pharmaceuticals, Carlsbad, California, USA.
Alexey RevenkoIonis Pharmaceuticals, Carlsbad, California, USA.
Brett MoniaIonis Pharmaceuticals, Carlsbad, California, USA.
Stephen N WaggonerImmunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Joseph S PalumboImmunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI LEE ARMISTEAD DENSON · 2007 to 2026
$24.4M
Tissue Repository CoreP30AR070549 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Leah Claire Kottyan · 2016 to 2026
$7.7M
Medical Scientist Training ProgramT32GM063483 · NIGMS · UNIVERSITY OF CINCINNATI · PI KHURANA HERSHEY, GURJIT K. · 2002 to 2022
$6.7M
Transcription Factor Genetics in LupusR01AR073228 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI KOTTYAN, LEAH CLAIRE, WAGGONER, STEPHEN N. · 2019 to 2023
$2.2M
Pathogenesis and therapeutic targeting of immune disordersT32AI118697 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI HILDEMAN, DAVID A · 2016 to 2020
$683k
NIAID NIH HHS T32 AI118697NIAMS NIH HHS P30 AR070549NIAMS NIH HHS R01 AR073228NIDDK NIH HHS P30 DK078392NIGMS NIH HHS T32 GM063483
6 · The paper itself

Abstract

Thrombin promotes the proliferation and function of CD8+ T cells. To test if thrombin prevents exhaustion and sustains antiviral T cell activity during chronic viral infection, we depleted the thrombin-precursor prothrombin to 10% of normal levels in mice prior to infection with the clone 13 strain of lymphocytic choriomeningitis virus. Unexpectedly, prothrombin insufficiency resulted in 100% mortality after infection that was prevented by depletion of CD8+ T cells, suggesting that reduced availability of prothrombin enhances virus-induced immunopathology. Yet, the number, function, and apparent exhaustion of virus-specific T cells were measurably unaffected by prothrombin depletion. Histological analysis of the lung, heart, liver, kidney, spleen, intestine, and brain did not reveal any evidence of hemorrhage or increased tissue damage in mice with low levels of prothrombin that could explain mortality. Viral loads were also similar in infected mice regardless of prothrombin levels. Instead, infection of prothrombin-depleted mice resulted in a severe, T cell-dependent anemia associated with increased hemolysis. Thus, thrombin plays an unexpected protective role in preventing hemolytic anemia during virus infection, with potential implications for patients who are using direct thrombin inhibitors as an anticoagulant therapy.

Indexed as

AnemiaCD8-Positive T-LymphocytesLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusProthrombinAnimalsDisease Models, AnimalFemaleMiceMice, Inbred C57BLThrombinViral LoadProthrombinThrombinAdaptive immunityHematologyImmunologyT cellsThrombin

Identifiers

PMID39820014
PMCPMC11949038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.